We first used the UALCAN platform to analyze the DNA methylation levels of CERCAM genes in patient tumor tissues with their matched normal tissues in the TCGA-HNSCC dataset (Fig. 8a), we found that the CERCAM gene showed lower methylation levels in tumor tissues, with a significant difference (P < 0.05). Here, CERCAM is linked to head and neck squamous cell carcinoma.